LIZZI, FEDERICA
LIZZI, FEDERICA
DIP. DI SCIENZE FARMACEUTICHE
Complementary medicinal chemistry-driven strategies toward new antitrypanosomal and antileishmanial lead drug candidates
2010 Cavalli A; Lizzi F ; Bongarzone S ; Belluti F; Piazzi L ; Bolognesi ML
Conjugation of Quinones with Natural Polyamines: Toward an Expanded Antitrypanosomatid Profile
2012 F. Lizzi; G. Veronesi; F. Belluti; C. Bergamini; A. López-Sánchez; M. Kaiser; R. Brun; R. L. Krauth-Siegel; D. G. Hall; L. Rivas; M. L. Bolognesi
Multi-target-directed drug design strategy: quinone derivatives designed to block amyloid-beta aggregation and to exert antioxidant effects
2007 Bolognesi ML; Lizzi F; Andrisano V; Bartolini M; Hrelia P; Tarozzi A; Tumiatti V; Melchiorre C.
Multitargeted drugs discovery: Balancing anti-amyloid and anticholinesterase capacity in a single chemical entity
2011 Bolognesi M.L.; Bartolini M. ; Tarozzi A.; Morroni F. ; Lizzi F. ; Milelli A. ; Minarini A. ; Rosini M.; Hrelia P.; Andrisano V.; Melchiorre C.
Parallel synthesis and biological evaluation of a small library of 2-phenoxy-1,4-naphthoquinone and 2-phenoxy-1,4-anthraquinone derivatives bearing antitrypanosomal and antileishmanial activity
2008 Maria Laura Bolognesi; Federica Lizzi; Christian Bergamini; Serena Leone; Romana Fato; Andrea Cavalli
Privileged structure-guided synthesis of quinazoline derivatives as inhibitors of trypanothione reductase
2009 Cavalli A; Lizzi F; Bongarzone S; Brun R; Luise Krauth-Siegel R; Bolognesi ML
Synthesis of a small library of 2-phenoxy-1,4-naphthoquinone and 2-phenoxy-1,4-anthraquinone derivatives bearing anti-trypanosomal and anti-leishmanial activity
2008 Bolognesi ML; Lizzi F; Perozzo R; Brun R; Cavalli A.